title: Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia.
abstract: BACKGROUND
  Hereditary thrombocythemia is a rare disease characterized by increased megakaryopoiesis and overproduction of platelets. Germ line mutations have been identified in the genes for thrombopoietin (THPO) and its receptor, MPL. A clustering of familial cases with the MPL-G1073A mutation that results in a serine to asparagine substitution (S505N) has been recently reported in Italy. Here we performed haplotype analysis in nine families (eight Italian and one Japanese) with hereditary thrombocythemia carrying the MPL-S505N mutation in the MPL gene.
  
  
  METHODS
  The MPL gene was examined by genomic DNA sequencing. Haplotype analysis was performed using microsatellites and single nucleotide polymorphisms.
  
  
  RESULTS
  Analysis of microsatellite markers and single nucleotide polymorphisms in the eight Italian families with hereditary thrombocythemia revealed the presence of a common haplotype compatible with a founder effect, which may have originated 23 generations ago. This haplotype was rarely observed in 132 unrelated individuals and was absent in a Japanese family with the MPL-S505N mutation.
  
  
  CONCLUSIONS
  The recurrent MPL-S505N mutation found in the eight Italian families with hereditary thrombocythemia is likely due to a founder effect.
authors.affiliation: Department of Biomedicine, Experimental Hematology, Basel University Hospital, Hebelstrasse 20, 4031 Basel, Switzerland.
authors.forename: Kun
authors.initials: K
authors.lastname: Liu
authors.forename: Maurizio
authors.initials: M
authors.lastname: Martini
authors.forename: Bianca
authors.initials: B
authors.lastname: Rocca
authors.forename: Christopher I
authors.initials: CI
authors.lastname: Amos
authors.forename: Luciana
authors.initials: L
authors.lastname: Teofili
authors.forename: Fiorina
authors.initials: F
authors.lastname: Giona
authors.forename: Jianmin
authors.initials: J
authors.lastname: Ding
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Komatsu
authors.forename: Luigi M
authors.initials: LM
authors.lastname: Larocca
authors.forename: Radek C
authors.initials: RC
authors.lastname: Skoda
mesh_terms: D000293:Adolescent; D000328:Adult; D044466:Asian People / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D019317:Evidence-Based Medicine; D005260:Female; D018703:Founder Effect; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D007223:Infant; D007558:Italy; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D053628:Receptors, Thrombopoietin / Q000235:genetics*; D013922:Thrombocytosis / Q000235:genetics*; D013926:Thrombopoietin / Q000235:genetics*; D044465:White People / Q000235:genetics*; D055815:Young Adult
chemical_list: D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; D013926:Thrombopoietin